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Abstract. N-myristoylation is a cotranslational modifi- 
cation involved in protein-protein interactions as well 
as in anchoring polypeptides to phospholipid bilayers; 
however, its role in targeting proteins to specific subcel- 
lular compartments has not been clearly defined. The 
mammalian myristoylated flavoenzyme NADH-cyto- 
chrome b 5 reductase is integrated into ER and mito- 
chondrial outer membranes via an anchor containing a 
stretch of 14 uncharged amino acids downstream to the 
NH2-terminal myristoylated glycine. Since previous 
studies suggested that the anchoring function could be 
adequately carried out by the 14 uncharged residues, 
we investigated a possible role for myristic acid in re- 
ductase targeting. The wild type (wt) and a nonmyris- 
toylatable reductase mutant (gly2--~ala) were stably ex- 
pressed in MDCK cells, and their localization was 
investigated by immunofluorescence, immuno-EM, and 
cell fractionation. By all three techniques, the wt pro- 
tein localized to ER and mitochondria, while the non- 
myristoylated mutant was found only on ER mem- 
branes. Pulse-chase experiments indicated that this 
altered steady state distribution was due to the mu- 
tant's inability to target to mitochondria, and not to its 
enhanced instability in that location. Both wt and mu- 
tant reductase were resistant to Na2CO  3 extraction and 
partitioned into the detergent phase after treatment of 
a membrane fraction with Triton X-114, demonstrating 
that myristic acid is not required for tight anchoring of 
reductase to membranes. Our results indicate that 
myristoylated reductase localizes to ER and mitochon- 
dria by different mechanisms, and reveal a novel role 
for myristic acid in protein targeting. 
N 
'-MVRXSTOVLAXION, which consists in the cotransla- 
tional attachment of the 14 carbon saturated fatty 
acid,  myristic acid,  via  an  amide  bond,  to  the 
NHz-terminal glycine of target proteins, is a highly specific 
modification required for the function of a number of reg- 
ulatory  proteins  and  enzymes.  The  myristoylating en- 
zyme(s) is located in the cytosol and transfers the myris- 
toyl  moiety  from  myristoyl-coenzyme A  to  the  NHz 
terminus of acceptor nascent chains, provided that their 
first five residues conform to a loose consensus sequence 
in which the NHz-terminal glycine (gly2) is essential. With 
one exception, N-myristoylation has been found to be  a 
constitutive and irreversible modification (for reviews see 
Johnson et al., 1994; Casey, 1995). 
Studies on a variety of N-myristoylated proteins suggest 
that myristic acid may have different roles when attached 
to different acceptor proteins. Its most obvious and simple 
function is that of contributing to the association of the 
modified protein to the cytosolic face of membranes. How- 
Address all correspondence to Nica Borgese, C.N.R. Cellular and Molec- 
ular Pharmacology Center, via VanviteUi 32, 20129 Milan, Italy. Tel.: (39) 
2-70146250. Fax: (39) 2-7490574. e-mail: Nica@Farmal.csfic.mi.cnr.it 
ever, myristic acid alone is not sufficient to anchor a pro- 
tein to the phospholipid bilayer, as indicated both by bind- 
ing studies on model peptides (Peitzsch and McLaughlin, 
1993)  and by the existence of soluble myristoylated pro- 
teins, such as calcineurin B (Aitken et al., 1982; Zhu et al., 
1995)  and the catalytic subunit of cAMP-dependent pro- 
tein kinase (Carr et al., 1982). More sophisticated roles for 
myristic acid include: (a) participation in a "switch" mech- 
anism permitting the protein to cycle in a regulated man- 
ner between membranes and the cytosol (McLaughlin and 
Aderem, 1995; Randazzo et al., 1995; Zozulya and Stryer, 
1992; Tanaka et al., 1995); (b) influencing protein confor- 
mation,  with  consequences  for  protein  stability  (Yone- 
moto et al., 1993)  or ligand binding (Franco et al., 1995; 
Randazzo et al.,  1995; Ames et al., 1995; and (c) promo- 
tion of protein-protein interactions (Linder et al.,  1991; 
Harris and Neil, 1994). 
As a result of its demonstrated role in protein-protein 
interactions, it seems possible that myristic acid, in addi- 
tion to participating in the anchoring of proteins to the 
phospholipid bilayer, might play a role in the selection of 
the target membrane to which the myristoylated protein 
binds, i.e., in protein targeting. However, since different 
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branes, it is clear that myristic acid by itself cannot consti- 
tute a targeting signal. Rather, it could be part of a more 
complex signal, or, by influencing protein conformation, it 
could be  instrumental in the display of a  signal located 
elsewhere on the protein molecule. Until now, it has been 
difficult to  discriminate  experimentally between  an  an- 
choring and a targeting role for myristic acid. This is be- 
cause  the  membrane-associated  myristoylated  proteins 
that have been investigated require the fatty acid for an- 
chorage, and the corresponding nonmyristyolated mutants 
are relocated to the cytosol (Cross et al., 1984; Graft et al., 
1989; Jones et al.,  1990; Mumby et al., 1990; Yu and Fel- 
sted,  1992; Busconi and Michel,  1993; D'Souza-Schorey 
and Stahl, 1995). 
An N-myristoylated protein that might allow the experi- 
mental distinction between a targeting and anchoring role 
for myristic acid is mammalian NADH-cytochrome (cyt)  1 
b5 reductase (generally referred to in this paper simply as 
"reductase") (Ozols et al., 1984). This protein inserts post- 
translationally into  ER  and  mitochondrial outer  mem- 
branes (MOMs) (Borgese and Pietrini, 1986; Borgese et al., 
1980;  Borgese and Gaetani, 1980)  via an NH2-terminal 
anchor,  which  is  myristoylated in  both  these  locations 
(Borgese and Longhi, 1990). The COOH-terminal catalytic 
domain is exposed to the cytosol (for review see Borgese 
et al.,  t993). The NH2-terminal anchoring sequence con- 
tains, in addition to myristic acid, a stretch of 14 uncharged 
amino acids, which, on the basis of fluorescence quantum 
yield studies on a  tryptophan residue contained therein, 
appears to interact directly with the interior of the lipid bi- 
layer (Kensil and Strittmatter, 1986). In vitro binding stud- 
ies have shown that myristic acid is not required for the in- 
teraction of reductase with liposomes (Strittmatter et al., 
1993), suggesting that the 14 uncharged residues are suffi- 
cient for anchoring and that the myristic acid may play a 
more subtle role, possibly in the selection of the target 
membrane. In the present study, we have tested this hy- 
pothesis by comparing the localization of a nonmyristoy- 
latable G2A mutant with that of the wild-type reductase in 
transfected cultured mammalian cells. We find that indeed 
the  mutant protein,  while remaining membrane  bound, 
has a dramatically altered subcellular distribution, in that 
it no longer localizes to mitochondria but retains its capac- 
ity to bind to ER membranes. 
Materials and Methods 
Plasmid Constructions 
DNA manipulations were carried out by standard procedures (Sambrook 
et al., 1989; Ausubel et al., 1987). Two cDNAs, coding for the rat wild- 
type myristoylated and for a G2A nonmyristoylatable form of reductase, 
were used in this study and are referred to as "wt" and "G2A" eDNA, re- 
spectively (see Fig. 1). Wild-type (wt) eDNA in the plasmid pGEM3 (cor- 
responding to the construct pGbk3 described in Pietrini et al., 1992) was 
used as template for the construction of the G2A mutant by PCR-assisted 
mutagenesis. The upper mutagenic primer, corresponding to nucleotides 
(nts) 25-47 of the sequence in Pietrini et al., (1988), was: 5' TTCGCCA_C_- 
1.  Abbreviations  used  in  this paper:  cyt,  cytochrome; ECL,  enhanced 
chemiluminescence; HMR, heavy microsomal fraction; MOM, mitochon- 
drial outer membrane; MR, microsomal fraction; PDI, protein disulfide 
isomerase; SRP, signal recognition particle; wt, wild type. 
CATGGCGGCCCAGCT  3'  (underlined  sequence is  NcoI  restriction 
site, containing the start codon; boldfaced C is the substituted base, gener- 
ating the G2A mutation); the lower primer, spanning nts 142-122  of the 
sequence in Pietrini et al. (1988),  was: 5' CTrGATGTCGGGGTrCTC- 
GAG 3' (underlined sequence is unique XhoI restriction site of reductase 
eDNA). After purification and digestion with XhoI and NcoI, the ll2-bp 
PCR-generated fragment was used to replace the corresponding fragment 
in the wt cDNA. The absence of unwanted substitutions in the mutant 
clone, as a result of the amplification process, was checked by sequencing. 
For expression in mammalian cells, wt and G2A eDNA were subcloned 
into the vector pCB6 (Brewer and Roth, 1991), in which the KpnI-BamHI 
fragment of the polylinker was replaced with the corresponding fragment 
of pBluescript I1 SK. wt eDNA was excised from pGEM3 with Kpnl up- 
stream of the eDNA, within the polylinker, and Bali in the 3' untranslated 
region (position 953),  and cloned into the KpnI and EcoRV sites of the 
modified pCB6  to  generate  pCB6wt.  G2A  cDNA  was  excised  from 
pGEM3 with KpnI and cloned into the KpnI site of the modified pCB6 to 
generate pCB6G2A. 
A plasmid coding for a fusion protein containing the first 11 residues of 
the gene 10 protein of phage T7 attached to the entire rat reductase se- 
quence was constructed by inserting a filled 998 Ncol-NdeI fragment of 
wt cDNA into the filled BamHI site of of the pET3a vector (Novagen, 
Madison, WI), generating the plasmid pET3a.wt. 
Antibodies 
Most of the immunofluorescence and immunoblotting experiments were 
performed with an anti-rat reductase antibody raised in a rabbit, using the 
bacterially expressed fusion protein encoded in pET3a.wt as immunogen. 
Inclusion bodies, containing the expressed fusion protein, were collected 
by sedimentation, solubilized with 0.1% SDS, emulsified in Freund's com- 
plete adjuvant, and injected into a rabbit subcutaneously at multiple sites 
on the back. The resulting antiserum was affinity purified on a strip of ni- 
trocellulose  containing  the  electrophoretically purified  fusion  protein 
(Olmsted, 1981). 
For double immunofluorescence labeling of reductase together with 
organelle marker  antigens for which rabbit polyclonal antibodies were 
available, a goat antiserum against the hydrophilic catalytic fragment of 
the enzyme purified from rat liver (Meldolesi et al., 1980) was used. For 
immunoprecipitation, an  antiserum raised in rabbit against the hydro- 
philic fragment of the enzyme was used. 
Other antibodies used in this study were: (a) a polyclonal antiserum, 
against bovine complex III, provided by R. Bisson (University of Padova, 
Italy); complex III was purified according to Yu et al., (1974) and antibod- 
ies were raised as described by Vaitukaitis (1981).  The antibodies recog- 
nized all of the polypeptides of the complex and were not cross-reactive 
with cytochrome oxidase polypeptides; (b) an anti-rat ER antibody (Lou- 
vard et al., 1982), provided by D. Louvard (Curie Institute, Paris, France); 
(c) an affinity-purified anti-dog ribophorin I  polyclonal antibody (Nic- 
chitta et al., 1991), obtained from G. Migliaccio (Istituto di Ricerche di Bi- 
ologia Molecolare, Rome, Italy);  (d) an mAb against protein disulfide 
isomerase (PDI) from StressGen (Victoria, British Columbia, Canada). 
Secondary FITC-labeled anti-rabbit IgG raised in donkey were from 
Jackson Immunoresearch Laboratories, Inc. (West Grove, PA). Biotin- 
lyated monoclonal anti-goat IgG and Texas red-conjugated streptavidin 
were from Sigma Chemical Co. (St. Louis, MO) and Amersham Intl. (Lit- 
tle Chalfont, UK), respectively. Goat anti-mouse and anti-rabbit IgG, 
conjugated to 5- and 10-nm gold particles, respectively, were from British 
Biocell Intl. (Cardiff, UK). 
Biochemical Assays 
Reduced and alkylated samples were analyzed by SDS-PAGE and blotted 
onto nitrocellulose as described (Borgese and Pietrini, 1986).  Samples 
were routinely analyzed on 11% gels; however, for blotting of ribophorin, 
7% gels were sometimes used. Immunostaining of blots was carried out ei- 
ther  by the  enhanced chemiluminescence (ECL)  procedure, using re- 
agents from Amersham Intl. according to the instructions of the manufac- 
turer,  or  with  125I-protein  A  (200,000  dpm/ml;  Amersham  Intl.)  as 
secondary reagent, followed by autoradiography, as previously described 
(Borgese and Pietrini, 1986).  For quantitative analysis of radioimmuno- 
blotting experiments, autoradiograms were scanned with a laser densitom- 
eter (Ultrascan XL; LKB Instruments, Inc., Gaithersburg, MD). Alterna- 
tively, radioactive bands were excised from the nitrocellulose and counted 
in an auto-gamma-counter (Cobra; Packard Instrument Co., Inc., Down- 
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ways analyzed to be sure that the assay was linear. 
Protein  was  assayed by the method of Lowry (Lowry  et  al.,  1951). 
NADH-[Fe(CN)6] 3- reductase and NADH-cyt c reductase were assayed 
as described in previous publications (Borgese and Pietrini, 1986; Shirabe 
et al., 1995). 
Transfection and Selection of CeU Lines Stably 
Expressing Reductase Forms 
MDCK II cells were grown in MEM with Earl's salts, supplemented with 
10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomy- 
cin, 10 mg/ml gentamicin, and maintained at 37°C under a 5% CO2 atmo- 
sphere. Cells grown on a plastic substrate to ~50% confluence were trans- 
fected by the calcium phosphate method (Graham and Van der Eb, 1973), 
using 1 p,g of Qiagen-purified plasmid per cm  2 of monolayer. Cells were 
incubated at 37°C for 6-9 h with the DNA precipitate in the presence of 
0.1 mM chloroquine diphosphate (Sigma Chemical Co.). After removal of 
the DNA-containing medium, the cells were subjected to a glycerol shock 
(MEM minus FCS containing 15% glycerol for 5 min at room tempera- 
ture)  (Parker  and Stark,  1979).  Transfected cell lines were selected by 
growth in the antibiotic G418 (0.9 mg/ml) (GIBCO BRL, Gaithersburg, 
MD).  Resistant colonies were  expanded in 24-well  petri  dishes. After 
reaching confluency, monolayers were washed free of medium and ana- 
lyzed by SDS-PAGE followed by immunoblotting. Reductase-expressing 
clones were further purified by limiting dilution. Stably transfected cell 
lines were maintained in culture in medium supplemented with 0.5 mg/ml 
G418. 
Immunofluorescence and Immunogold-EM 
Cells plated on 1.7 ×  1.7 cm  2 glass coverslips were grown to 50% conflu- 
ency, and then fixed with 4% paraformaldehyde in 0.120 M sodium phos- 
phate buffer, pH 7.4, for 30 min at 37°C. The monolayers were permeabi- 
lized and processed for immunofluorescence as described (De Silvestris et 
al.,  1995).  Preparations  were  observed using a  microscope  (Axioplan; 
Zeiss, Oberkochen, Germany) equipped for epifluorescence. 
For immunogold-EM, cells plated on 10-cm petri dishes were detached 
by trypsinization, collected by centrifugation, and fixed for 30 min on ice 
with 4%  paraformaldehyde and 0.2%  glutaraldehyde in 0.1  M  sodium 
phosphate buffer, pH 7.3.  Cell pellets were equilibrated in concentrated 
sucrose, frozen, sectioned, incubated with antibodies, postfixed, stained, 
and embedded as previously described (Bassetti et al., 1995). The sections 
were first incubated with anti-PDI mAbs, used as a marker for the ER, 
followed by anti-mouse IgG-10-nm gold particle  conjugates, and  then 
with  anti-reductase  antibodies  followed  by  anti-rabbit  IgG-5-nm gold 
particle  conjugates. Stained  sections were  observed and  photographed 
with a  CM10 electron microscope (Philips Electronic Instruments, Inc., 
Mahwah, N J). 
To  quantitate  the  results obtained  with  the immunogold technique, 
fields containing areas of ER and mitochondria were photographed at a 
magnification of 21,000 and printed  with further 2.5-fold enlargement. 
Density of gold particles in cytoplasmic areas not containing mitochondria 
was determined using a calibrated grid, composed of 0.25 × 0.25-g,m cells, 
randomly placed over the prints. Grid cells (0.0625  t~m  2 areas) that con- 
tained zero or one 10-nm gold particles were classified as PDI negative, 
while those containing two or more were classified as PDI (ER) positive. 
5-nm gold particles (reductase) were counted in both PDI-positive and 
-negative areas. The average density of gold particles in PDI-positive and 
-negative areas for each micrograph was calcuated from the total number 
of particles counted in each of the two areas, divided by the total PDI-pos- 
itive or -negative area  (number of grid cells  ×  0.0625  ~m  2) examined. 
Density of gold particles over mitochondria was estimated within areas 
delimited by a contour line traced at a distance of ~12 nm from the mar- 
gin of the mitochondrial profiles. The linear density was determined by 
counting particles that fell within 12 nm on either side of the outer mem- 
brane. Mitochondrial areas and contour lengths were measured with the 
NIH Image program, after generating electronic versions of the prints. 
Cell Fractionation 
Cells grown to ~70%  confluence on 175-cm  2 petri dishes were washed 
free of medium with PBS containing 5 mM EDTA (PBS-EDTA), scraped 
from the dishes with a rubber policeman, and recovered by centrifugation 
(130 g  for 10 min). After resuspension in 2 ml homogenization buffer 
(0.25 M sucrose, 0.1 mM EDTA, 20 mM Tris-HC1, pH 7.4,  1 mM PMSF, 
0.5 p,g/ml leupeptin, 0.7 v,g/ml pepstatin, 2  p~g/ml aprotinin), cells were 
again sedimented at 325 g for 7 rnin in a refrigerated microfuge. Cells were 
then incubated for 5 min on ice in 0.75 ml of hypotonic buffer (20 mM Tris 
HC1, pH 7.4, 0.1 mM EDTA, 15 mM KC1). After addition of an equal vol- 
ume of 2  ×  concentrated homogenization buffer, cells were ruptured by 
10 passages through a cell cracker with a 0.0007-inch clearance. The ho- 
mogenate was centrifuged at 780 g for 10 min to sediment nuclei. The nu- 
clear pellet was resuspended in 1 ml of homogenization buffer, and then 
recentrifuged as above. The two supernatants were combined and centri- 
fuged again as above, and the resulting postnuclear supernatant, contain- 
ing 60-70%  of the protein of the total homogenate, was centrifuged at 
9,300 g for 10 min to sediment mitochondria. The mitochondrial pellet was 
washed twice by resuspension in 0.4 M  sucrose containing the same ions 
and protease inhibitors as the homogenization buffer, and centrifugation 
was performed at 6,000 g for 10 min. The postmitochondrial supernatant 
was centrifuged at 15,000 g for 10 min to obtain a heavy microsomal frac- 
tion  (HMR).  The  resulting supernatant was  centrifuged for 45  min at 
150,000 g in the TLA-100.3 rotor (Beckman Instruments, Inc., Palo Alto, 
CA) to obtain a  microsomal pellet (MR) and a high speed supernatant. 
Pellets were resuspended in a small volume of homogenization buffer. 
Immunoprecipitation 
Suspensions containing metabolically labeled ceils or cell fractions were 
lysed with an equal volume of lysis buffer (50 mM Tris-Cl, pH 7.5, 20 mM 
EDTA, 0.3 M  NaCl, 4% Triton X-100, 2 mM PMSF, 1 p.g/ml leupeptin, 
1.4 ixg/ml pepstatin, 4 p,g/ml aprotinin) for 10 min on ice. Lysates were de- 
pleted of nuclei by centrifugation at 800 g  for 10 min, and then supple- 
mented with methionine, cysteine, and gelatin to final concentrations of 
0.5 mM, 0.25 mM, and 0.25%, respectively. After clarification by centrifu- 
gation (12,0000 g, 10 min), the lysates were incubated overnight at 4°C 
with anti-reductase antiserum at 1:50 dilution. Protein A-Sepharose CI-4B 
beads (Pharmacia, Uppsala, Sweden) in excess of the serum IgG were 
added, and the samples were incubated in a multivortex for I h in the cold 
room. Protein A  beads were collected by low speed centrifugation and 
washed twice with TBS containing 0.5% Triton X-100 and once with the 
same buffer without detergent. The beads were then heated in SDS solu- 
bilization buffer, and the released, reduced proteins were alkylated and 
analyzed by SDS-PAGE. Immunoprecipitated reductase was detected by 
fluorography (Bonner and Laskey, 1974)  or by autoradiography of a blot 
of the gel. 
Metabolic Labeling and Pulse-Chase Experiments 
Before labeling with 3H-myristic acid (16 Ci/mmol from Dupont-New En- 
gland Nuclear, Wilmington, DE), ~70%  confluent cells were incubated 
for 45  min in medium containing dialyzed and delipidated  (Chain and 
Knowles, 1976) FCS. This medium was replaced with fresh medium con- 
taining similarly treated FCS, to which the tritiated fatty acid, dissolved in 
a small volume of DMSO, was added to a final concentration of 335 p~Ci/ml. 
Cells were incubated with the tritiated fatty acid for 6 h, and then pro- 
cessed for immunoprecipitation and fluorography. 
Before labeling with 35S-amino acids, cells grown to N70% confluence 
were incubated for 45 min in medium lacking methionine and cysteine and 
containing dialyzed FCS. The cells were then incubated in the same me- 
dium, but containing 35S-translabel (ICN Pharmaceuticals, Costa Mesa, 
CA) at concentrations and for the times specified in the figure legends. In 
pulse-chase experiments, after the incubation with radioactive amino ac- 
ids, monolayers were  chilled,  washed free  of radioactive  medium, and 
then returned to the incubator with complete medium. Mitochondrial and 
heavy microsomal fractions were prepared from cells arrested at the dif- 
ferent chase times and subjected to immunoprecipitation with anti-reduc- 
tase antibodies. The immunoprecipitates were analyzed by SDS-PAGE 
followed by blotting. An evaluation of the ratio of metabolically labeled 
reductase molecules to total reductase molecules in the immunoprecipi- 
tates  ("metabolic  specific radioactivity")  was  obtained  as  follows:  the 
blots, which contained all the immunoprecipitates from one experiment, 
were first directly exposed to x-ray film. The 35S-content of the bands was 
quantitated by scanning the developed films with an LKB Ultroscan XL 
laser densitometer. The total amount of reductase (35S-labeled  plus unla- 
beled) in the bands was then evaluated by radioimmunoblotting. Bound 
125I-protein  A  was determined by cutting out the bands and counting 
them in a ~/-counter. The ratio of 3sS (area from scanning) to 12sI counts 
was taken as a measure of the metabolic specific radioactivity. Since the 
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of time of exposure of the unprocessed blots and of the specific radioactiv- 
ity of the l~I-protein A, for each experiment, the ratio for each fraction 
and each time point was normalized to the average ratio obtained in both 
cell fractions at all time points. 
Treatment of Membranes with Na2CO  3 or Triton X-114 
A  postnuclear supernatant (see Materials  and Methods [Cell  fraction- 
ation]), prepared from cells expressing wt or G2A reductase, was centri- 
fuged at 150,000  g  for 45 rain in the TLA-100.3 rotor to obtain a  total 
membrane pellet. The pellet was resuspended in a  small volume of ho- 
mogenization buffer. 100-v.l  aliquots containing 150 I~g of protein were 
supplemented with an equal volume of 0.2 M Na2CO3, pH 11.2, incubated 
on ice for 30 min, and then centrifuged at 60,000 rpm for 1 h in the TLA- 
100 rotor. Pellets were resuspended with 0.1 M Na2CO  3 to the same final 
volume as the supernatants. Equal aliquots of pellets and supernatants 
were analyzed by SDS-PAGE followed by ECL immunoblotting. 
Aliquots of membrane suspensions (30-100 wg protein) were treated 
with Triton X-114 in a  total volume of 150 Ixl as described by Bordier 
(1981). Equal aliquots of aqueous and detergent phases were analyzed by 
SDS-PAGE followed by ECL immunoblotting. 
Results 
Expression of wt and G2A Reductase in MDCK Cells 
Cyt b5 reductase is anchored to the phospholipid bilayer 
via an NH2-terminal anchor containing a stretch of 14 un- 
charged amino acids (underlined in Fig. 1) preceded by the 
consensus sequence for myristoylation (boldfaced in Fig. 1), 
which results in myristoylation of Gly in position 2 (boxed 
in Fig. 1) after removal of the initiator Met. To investigate 
the role of myristic acid in the localization of reductase, we 
constructed a  mutant in which  Gly2 was changed to Ala 
(G2A mutant). MDCK cells were transfected with cDNAs 
coding for the wt or mutant reductase, and G418-resistant 
clones,  stably  expressing  the  reductase  forms,  were  se- 
lected.  The  results  presented  in  this  paper were  all ob- 
tained  with  a  single  clone  for each  reductase  form,  re- 
ferred to respectively as wt- and G2A-MDCK; however, at 
least three independent clones for each construct, as well 
as transiently transfected CV1 cells, were analyzed by im- 
munofluorescence and yielded indistinguishable results. 
To compare the expression of the transfected reductase 
forms in our cell lines with that of endogenous reductase 
and to directly assess the lack of myristyolation of the mu- 
tant,  we  incubated  the  transfected  and  control  MDCK 
lr~n 
MetlGlYlAla Gin Leu Ser Thr Leu Set Arg Val Val Leu Ser Pro Val 
17  24 
Tro Phe Val Tvr Ser Leu Phe Met Lys  ..... 
Figure 1.  Membrane anchor of rat NADH-cyt b5 reductase.  The 
NHz-terminal  25 residues  are shown.  The residues  in boldface 
constitute  the consensus sequence for myristoylation.  Met in po- 
sition 1 is removed by an aminopeptidase, and gly2 is then myris- 
toylated. The  14 underlined residues  constitute a hydrophobic 
stretch that interacts with the phospholipid bilayer (see text). Met 
24 (italics) is the last residue of the hydrophobic stretch, which is 
followed  by the  COOH-terminal 275-residue,  cytosolically  ex- 
posed, catalytic domain. Met 24 also is the start codon of the solu- 
ble form of reductase, expressed in erythrocyte precursors from 
an alternate transcript  (Pietrini et al., 1992). 
cells  either  with  35S-labeled  amino  acids  or  3H-myristic 
acid, and then analyzed immunoprecipitates from the la- 
beled cells by SDS-PAGE fluorography. As shown in Fig. 2, 
the labeling pattern of total proteins of control and trans- 
fected cells was indistinguishable (lanes 1-3). In contrast, 
detectable 35S-labeled reductase polypeptide was not im- 
munoprecipitated  from  control  cells  (lane  4),  while  a 
prominent band at the expected position was visible in im- 
munoprecipitates from both wt and G2A reductase cells 
(lanes 5 and 6). When 3H-myristic acid was used as label- 
ing agent, only immunoprecipitates from cells expressing 
wt reductase contained a radioactive polypeptide (lane 8), 
demonstrating that the G2A mutant was not myristoylated 
(lane 9), as expected. This experiment also showed that re- 
ductase endogenous to MDCK cells was expressed at suf- 
ficiently low levels to not interfere with the analysis of the 
transfected enzyme forms. 
Although the G2A mutation is at the extremity of the 
NH2-terminal anchoring domain of the reductase,  it was 
possible that it had an indirect effect on the conformation 
of the catalytic domain, resulting in the production of non- 
native,  possibly  aggregated  enzyme.  To  investigate  this 
point, the transfected cell lines were analyzed for reduc- 
tase enzyme activity (Table I). Two different enzyme assays 
specific for reductase,  the NADH-cyt c and the NADH- 
[Fe(fN)6] 3- reductase assays, were used. With the NADH- 
cyt c reductase assay, wt and G2A-expressing cells showed 
4.2- and sevenfold more activity, respectively, than control 
cells (Table I, second column). The increase in activity was 
more pronounced with the NADH-[Fe(CN)6] 3- reductase 
assay (5.4- and 11.7-fold over control cells for wt and G2A 
cells, respectively; fourth column). The lower increase ob- 
served with the first assay may be due to its dependency 
on endogenous membrane-bound cyt bs, which serves as 
intermediate  electron  carrier and  is  present  at very low 
concentrations in MDCK cells (our unpublished observa- 
tions). The higher activity of the G2A-MDCK relative to 
wt cells could in large part be explained by their higher re- 
ductase protein content,  as is apparent from the data of 
the third and fifth columns, in which the reductase activity 
in  the  homogenates is  normalized to reductase  content, 
determined  by radioimmunoblotting.  The  data,  normal- 
ized in this way, reflect the  turnover number of the  en- 
zyme and are similar for the two reductase forms, although 
the value for the mutant enzyme remained slightly higher. 
The results indicate in any case that the G2A mutation did 
not  lead  to  loss  of function  of the  catalytic  domain,  in 
agreement with previous data on the bacterially expressed 
enzyme (Strittmatter et al., 1993). 
Table L Reductase Activity in Total Homogenates of Control 
(Nontransfeeted), wt, and G2A MDCK 
Cell line  NADH-cyt c reductase  NADH-[Fe(CN)6]  3- reductase 
nmol/min/  nmol/min/  nmol/min/  nmol/min/ 
mg protein*  cpm X  10  at  mg protein*  dpm )< 10  ~t 
Control  46.9  ND  786  ND 
Wt  199.6  41.7  4,256  889 
G2A  328.3  50.8  9,170  1,420 
*Activity normalized to total protein in the homogenates. 
*Activity normalized to reductase antigen quantitated by 125I-protein  A radioimmuno- 
blouing (dpm in bands excised from blots; see Materials and Methods). 
The Journal of Cell Biology, Volume 135, 1996  1504 Figure 2.  SDS-PAGE  analysis  of wt  and  G2A  reductase  ex- 
pressed in transfected MDCK ceils shows lack of myristoylation 
of G2A mutant. Control (C, lanes 1, 4, and 7), wt (lanes 2, 5, and 
8), or G2A (lanes 3, 6, and 9) MDCK cells, grown to N70% con- 
fluency in 10-cm petri dishes, were incubated with either 0.1 mCi/ 
ml 3SS-labeled methionine +  cysteine  for 90 min (lanes 1--6) or 
0.335 mCi/ml 3H-myristic acid for 6 h. Cell lysates were prepared 
in total volumes of 1 ml, and reductase was immunoprecipitated. 
Samples were analyzed by 11% SDS-PAGE followed by fluorog- 
raphy.  (Lanes 1-3) 35S-labeled proteins of total lysates  (1  ixl); 
(lanes 4-6) immunoprecipitates obtained from 100 I~135S-labeled 
lysates; (lanes 7-9) immunoprecipitates obtained from 200 Ixl 3H- 
myristic  acid-labeled lysates.  Lanes 1-6 and 7-9 were exposed 
overnight and for 5 d, respectively. Numbers on the left represent 
M r  ×  10  -3 of molecular weight standards from Bio Rad Labora- 
tories (Richmond, CA). 
Different Localization  of wt and G2A Reductase 
Assessed by Immunofluorescence and Immuno-EM 
From biochemical studies,  it has been known for a  long 
time that, in liver, reductase is localized to the MOM and 
to ER membranes (Borgese and Pietrini,  1986; Meldolesi 
et al., 1980; Sottocasa et al., 1967), and that in both its loca- 
tions it is myristoylated (Borgese and  Longhi,  1990).  As 
demonstrated in Figs. 3, 4, and 7 A, also in transfected cul- 
tured cells, the product of wt reductase cDNA showed the 
same double localization previously found for the endoge- 
nous enzyme in liver. 
When wt-MDCK cells were stained with an anti-reduc- 
tase antibody, a punctate pattern superimposed on a more 
diffuse reticular staining was observed (Figs. 3 A  and 4 A). 
We consistently observed that  not all cells were positive 
for reductase (Fig. 3, asterisks). Since our cells belonged to 
a single clone, we presume that this heterogeneity may be 
attributed  to temporal alterations  in the  level of expres- 
sion of the transfected eDNA as a result of changes in the 
metabolic state of the cells. Fig. 3 shows the results of an 
experiment in which cells were doubly immunostained for 
reductase (A) and for complex III, as a  marker for mito- 
chondria (B). The punetate portion of the anti-reductase 
antibody  staining  corresponded  closely  to  the  pattern 
obtained with the anti-complex III antibody. The arrow- 
heads  in A  and  B  highlight  some of the  points of coin- 
cident staining. However, the more reticular, diffuse stain- 
ing obtained with the anti-reductase antibody was not seen 
with the anti-complex III antibody. Moreover, anti-reduc- 
tase dearly stained the nuclear envelope (A, arrow), indi- 
cating the presence of wt reductase on the ER. The pres- 
ence of wt reductase on the ER was confirmed by a double 
immunostaining  experiment  with  anti-reductase  and  an 
antibody directed  against  ER  membrane proteins  (Lou- 
vard et al.,  1982)  (Fig. 4), from which the coincidence of 
the reductase reticular staining and the ER pattern was ev- 
ident (compare Fig. 4 A  and 4 B). 
Having characterized  the  immunofluorescence pattern 
for wt reductase, we next analyzed the cells expressing the 
mutant G2A reductase (Figs. 5 and 6). As can be seen in 
Fig. 5 A, the mutant reductase did not localize to the dis- 
crete structures positive for the wt enzyme (Fig. 5 B) and 
shown to be mitochondria. Rather, it showed exclusively a 
diffuse reticular  staining.  Double  staining with the  anti- 
reductase and the anti-ER antibodies revealed a high de- 
gree  of coincidence  between  the  two  patterns  (Fig.  6). 
These results thus  suggest that  the  nonmyristoylated re- 
ductase is capable of associating with the ER but has lost 
its capacity to bind to the MOM. 
To confirm these results at the ultrastructural level, ul- 
trathin cryosections were analyzed in double-labeling ex- 
periments with the immunogold technique, using anti-PDI 
antibodies to identify the ER. As shown in Fig. 7 A, wt re- 
ductase  (small gold particles) was present both  on mito- 
chondria and on PDI-positive structures (large gold). The 
Golgi complex (G) was negative both for wt-reductase and 
for PDI. Small gold particles were present at the periphery 
of the mitochondria, as shown in the inset of Fig. 7 A, con- 
sistent with the MOM localization of reductase. Some ap- 
parently more internal labeling might be attributable to a 
tangential  orientation of the section plane. However, we 
cannot rule out that a part of wt reductase has an inverted 
topology, with the catalytic domain facing the intermem- 
brane space. In contrast with the situation with wt-reduc- 
tase, mitochondria of G2A-expressing ceils were labeled 
poorly or not at all, as illustrated in Fig. 7 B, although lo- 
calization on PDf-positive structures was evident (Fig. 7 B, 
arrows and inset). 
The results of immuno-EM localization are presented in 
quantitative form in Table II. Evaluation of reductase ex- 
pression in the ER was done with a calibrated grid on cy- 
toplasmic  areas  not  containing  mitochondria.  Grid  cells 
were  defined  as  PDI  positive  or  negative,  according  to 
their  content of 10-nm gold particles  (see  Materials  and 
Methods). As can be seen from the third and fifth columns 
of  Table  II,  reductase  labeling  was  nearly  three  times 
higher  in  PDI-positive areas  than  in  PDI-negative ones, 
and the extent of labeling was similar for wt and G2A cells 
in this experiment. In contrast, in wt cells the extent of la- 
beling of mitochondria was >10-fold higher than that of 
G2A cells, where the density of 5-nm gold particles over 
mitochondria  was  similar to  that  found  in  the  nonmito- 
Borgese et al. Myristic Acid and Protein Targeting  1505 Figure 3.  Double-staining  immunofluorescence of wt-MDCK cells: comparison between localization  of reductase and mitochondria. 
Cells expressing wt-reductase  were doubly stained with a goat polyclonal antibody against rat cyt b  5 reductase and a rabbit polyclonal 
antibody against bovine complex III. Reductase and complex III were revealed with biotinylated monoclonal anti-goat IgG, followed 
by Texas red-conjugated streptavidin  (A) and FITC-conjugated donkey anti-rabbit IgG (B), respectively. The figure shows the same 
field of ceils viewed under the rhodamine (A) or FITC (B) filter. Reductase (A) shows a punctate pattern superimposed on a more dif- 
fuse reticular  stain. The punctate pattern is in great part coincident with the pattern obtained with the anti-complex III antibody.  Ar- 
rowheads in A and B indicate some of the points of coincidence. In addition, the anti-reductase antibody clearly stains the nuclear enve- 
lope (A, arrow),  which is not stained by the anti-complex III antibody (B): Asterisks in both panels indicate cells that express low levels 
of reductase.  Bar, 5 ~m. 
chondrial PDI-negative areas (Table II, seventh column). 
The same result was obtained when the linear density of 
gold particles per contour length of mitochondrial profiles 
was calculated (ninth column). Thus, with similar levels of 
labeling of the ER, the G2A-expressing cells showed dra- 
matically reduced levels of mitochondrial labeling, indicat- 
ing that lack of myristoylation interferes with MOM local- 
ization of the reductase. It should be mentioned that the 
data of Table II cannot be used to directly compare label- 
ing density in the ER with that in mitochondria, since the 
grid method used to define PDI-positive and -negative ar- 
eas results in the inclusion of cytoplasm surrounding  ER 
cisternae in the total areas used to calculate gold particle 
density. 
Comparison of  Localization of wt and G2A Reductase 
by Cell Fractionation 
To obtain further quantitative evaluation of the different 
subcellular  distribution  of the  two  reductase  forms, cell 
fractions from wt- and  G2A-MDCK were  prepared  and 
analyzed by immunoblotting.  A  postnuclear supernatant 
obtained from each cell line was subjected to differential 
centrifugation to obtain mitochondrial (Mt), rapidly sedi- 
menting (heavy) microsomal (HMR),  microsomal (MR), 
and high speed supernatant (Sup) fractions (Fig. 8).  Ali- 
quots deriving from the same number of cells were ana- 
lyzed for a 13-kD polypeptide recognized by the anti-com- 
plex III antibody, for ribophorin I as an ER marker, and 
for reductase (Fig. 8). As can be seen in the lower panel of 
Fig. 8 A, the complex III antibody was almost exclusively 
recovered in the mitochondrial fraction in both cell lines. 
In both cell lines, most of the ribophorin I was recovered 
in the microsomal fraction, but appreciable amounts were 
found  also  in  the  mitochondrial  and  heavy microsomal 
fractions (Fig. 8 A, upper panel). If expressed on a protein 
basis,  the  fraction  most  enriched  in  ribophorin  was  the 
heavy microsomal one. The ribophorin content of the mi- 
tochondrial fraction on a protein basis was 30-40% that of 
the  heavy microsomal fraction  (see  Fig.  10).  As  can  be 
The Journal of Cell Biology, Volume 135, 1996  1506 Figure  4.  Double-staining  immunofluorescence  of  wt-MDCK 
ceils: comparison between localization  of reductase and of ER. 
Cells expressing  wt-reductase were doubly stained with  a goat 
polyclonal antibody against rat cyt b 5  reductase and a rabbit poly- 
clonal  antibody against  ER membrane proteins.  Reductase and 
ER were revealed with biotinylated monoclonal anti-goat IgG, 
followed  by Texas red-conjugated streptavidin  (A) and FITC- 
conjugated donkey anti-rabbit IgG (B), respectively.  The figure 
shows the same field of cells viewed under the rhodamine (A) or 
FITC (B) filter. Reductase yields the usual punctate plus reticular 
staining. The reticular staining is coincident with the ER pattern. 
The boxed area in both panels encloses an area where the coinci- 
dence is particularly  clear. Bar, 5 p.m. 
seen from the middle panel of Fig. 8 A, the distributions of 
wt and G2A reductase differed markedly. While the wt en- 
zyme was distributed  roughly equally between the mito- 
chondrial and microsomal fractions, the distribution of the 
G2A mutant was similar to that of ribophorin, suggesting 
that the presence of the mutant enzyme in the mitochon- 
drial fraction was due to contamination with ER elements. 
Both wt and G2A reductase were present at nearly unde- 
tectable levels in the high speed supernatant.  The reduc- 
tase  and  ribophorin  content  was  quantitated  from blots 
like the one shown in Fig. 8 A, and the ratio of reductase 
to ribophorin  was calculated  and  normalized to the  one 
found in the microsomal fraction in each experiment. As 
shown in Fig. 8 B, the ratio of wt reductase to ribophorin 
was over two times higher in  the  mitochondrial fraction 
than  in  the  two  microsomal  fractions,  suggesting  that 
>50%  of the reductase in the mitochondrial fraction was 
endogenous to mitochondria and not caused by cross con- 
tamination.  In  contrast,  the  ratio  of  reductase  to  ribo- 
phorin for the G2A mutant was the same in mitochondrial 
and microsomal fractions, indicating that all the reductase 
recovered in  the  mitochondrial fraction was contributed 
by contaminating microsomes. In one experiment, we also 
determined the reductase content of the fractions with the 
NADH-[Fe(CN)6]  3- assay, and the ratio of reductase ac- 
tivity to ribophorin (determined by immunoblotting) was 
calculated  and  normalized to  the  ratio  found  in  the  mi- 
crosomal fraction.  As  shown  in  Fig.  8  C,  the  result  ob- 
tained with this procedure agreed well with the data ob- 
tained on the basis of immunoblotting. 
wt and G2A Reductase Both Behave as Integral 
Membrane Proteins 
Although  G2A reductase  was associated with ER mem- 
branes on the  basis of both morphological and cell frac- 
tionation experiments, it was possible that, because of the 
absence  of myristic  acid,  it  was  only weakly associated 
with  the  phospholipid  bilayer.  To  investigate  a  possible 
role of myristic acid in strengthening  the  association be- 
tween reductase and membranes, we treated a total mem- 
brane fraction from wt- and G2A-MDCK cells with agents 
routinely used  to discriminate  between  integral  and  pe- 
ripheral membrane proteins (Fig. 9). Both wt and G2A re- 
ductase were resistant to extraction with Na2CO3, pH 11.2 
(Fig. 9, lanes 1-4), and both were recovered exclusively in 
the  detergent  phase  after  extraction  with  Triton  X-114 
(Fig.  9,  lanes 5-8). Thus,  by both  these  criteria,  wt  and 
G2A  reductase  were indistinguishable  and  behaved like 
integral membrane proteins. 
Pulse-Chase Analysis of Targeting of wt and 
G2A Reductase 
The absence of G2A reductase from mitochondria could 
be explained either by a  failure of the newly synthesized 
mutant to bind to the MOM or by a high degree of insta- 
bility of the  enzyme on the  MOM  but not on ER mem- 
branes.  In the  latter  case,  after binding  to  the  MOM,  it 
would be rapidly degraded,  resulting in  a  low, undetect- 
able,  steady state reductase  concentration  on that mem- 
brane. To distinguish  between these two possibilities, we 
carried out a pulse-chase experiment in which we analyzed 
the degree of metabolic labeling in the mitochondrial and 
heavy microsomal fraction of wt and G2A reductase after 
various times of chase (Fig. 10). We normalized the amount 
of metabolic labeling to the amount of total reductase in 
each immunoprecipitate (see Materials and Methods).  In 
this way, we corrected for differences in reductase recov- 
ery in the immunoprecipitates (caused by the low [~50%] 
efficiency  of  immunoprecipitation  of  our  antibodies). 
Moreover, this method permitted direct comparison of the 
extent of labeling of reductase in the two cell fractions, in- 
dependent  of its concentration within the fraction. If the 
instability  hypothesis  was  the  correct  one,  we  expected 
that  G2A reductase  in  the  mitochondrial fraction would 
show  a  high  degree  of metabolic labeling  at  early  time 
points, with  a  rapid  decrease, caused by degradation,  to 
the level observed in the HMR fraction, when all the la- 
beled reductase  immunoprecipitated from the  mitochon- 
drial fraction would be due to microsomal contamination. 
The latter can be estimated by the ratio of ribophorin con- 
tent of the two fractions, and it is given in the lower line of 
Fig. 10. As can be seen from Fig. 10, the extent of labeling 
of both wt and G2A reductase did not change significantly 
in either cell fraction during nearly 4 h of chase, indicating 
that both forms of reductase were stable.  Moreover, the 
metabolic specific radioactivity of G2A reductase  in  the 
Borgese et al. Myristic Acid and Protein Targeting  1507 Figure 5.  Comparison of wt and G2A localization in stably expressing MDCK cells. G2A- (A) and wt- (B) MDCK were immunostained 
with a polyclonal rabbit anti-rat reductase antibody, which was revealed by biotinylated goat anti-rabbit IgG, followed by Texas red- 
conjugated  streptavidin,  wt reductase shows the expected punctate (mitochondria) plus reticular  (ER) staining. In two ceils in the lower 
part of the field of B, mitochondria appear as elongated bodies. Their appearance as dots or more elongated bodies depends on their 
orientation with respect to the monolayer. In G2A reductase--expressing  cells (A), the antibody does not stain any discrete  structures 
reminiscent  of mitochondria,  but it yields only the diffuse reticular staining characteristic  of the ER. Bar, 5 t~m. 
mitochondrial fraction was not significantly different from 
the value found for the mutant in the  heavy microsomal 
fraction (Fig. 10, right), as would be expected if the meta- 
bolically labeled  G2A  reductase  recovered in  the  mito- 
chondrial fraction is nearly exclusively due to contaminat- 
ing  microsomes. The  results  of this  experiment are  thus 
consistent with the hypothesis that G2A reductase fails to 
associate with the MOM. The alternative, unlikely inter- 
pretation is that it does associate but is degraded within 
the 5-min pulse period of the experiment. 
Discussion 
Although N-myristoylation by itself is not sufficient to an- 
chor  proteins  to  the  phospholipid  bilayer  (Peitzsch  and 
McLaughlin,  1993), it can collaborate with other features 
of modified proteins to ensure docking to the cytoplasmic 
face of a variety of membranes. For src and myristoylated 
alanine-rich protein kinase C substrate, basic residues near 
the NH2 terminus, which interact with acidic phospholip- 
ids, are required,  in addition to myristic acid for associa- 
tion  with membranes (Sigal et al.,  1994;  Taniguchi  and 
Manenti,  1993).  In  other  proteins  like arf or  recoverin, 
myristic  acid  is  part  of a  switch  mechanism,  permitting 
membrane association when a ligand such as GTP or Ca  2÷ 
occupies a  binding site elsewhere within the polypeptide 
(Randazzo et al.,  1995;  Zozulya and Stryer, 1992).  In no 
myristoylated  protein,  however,  has  a  role  for  myristic 
acid in the selection of the target membrane been demon- 
strated. In the present study, we have chosen NADH-cyto- 
chrome b5 reductase as model protein to address the ques- 
tion  of  the  role  of  myristic  acid  in  targeting.  Since  a 
hydrophobic stretch of amino acids slightly downstream to 
the NH2 terminus interacts with the phospholipid bilayer 
(Kensil and Strittmatter, 1986), this enzyme has offered us 
the possibility to investigate the targeting role of N-myris- 
toylation independently from its anchoring function. 
One Protein Is Targeted to Two Compartments by Two 
Different Mechanisms 
Studies on man (Katsube et al., 1991; Shirabe et al., 1994) 
and rat (Pietrini et al., 1992, 1988) indicate that NADH-cyt 
b5 reductase is encoded in one gene, which generates both 
the soluble, erythrocyte-specific form and the ubiquitously 
expressed,  myristoylated forms.  The  latter  is  docked  to 
membranes via an NHz-terminal anchor, containing 14 un- 
charged  residues,  and  exposes its  COOH-terminal  cata- 
lytic domain to the cytosol (for review see Borgese et al., 
1993). In man, a point mutation causing the complete ab- 
sence of immunologically measurable  reductase  resulted 
in the  absence of both ER and MOM reductase  enzyme 
activity  in  cultured  fibroblasts,  demonstrating  that  the 
same gene product is localized to two different compart- 
ments (Shirabe et al., 1995). Previous biochemical studies 
had indicated that the same reductase molecule is present 
The Journal of Cell Biology,  Volume 135, 1996  1508 Figure 6.  Double-staining immunofluorescence of MDCK cells ex- 
pressing  G2A reductase reveals only an ER localization  for the 
mutant  reductase.  G2A-MDCK  cells  were  doubly  immuno- 
stained with  anti-reductase (A) and anti-ER antibodies  (B),  as 
explained in the legend to Fig. 4. An essentially identical pattern 
is obtained with the two antibodies  in all cells. Bar, 5 Ixrn. 
on these  two membranes (for review see Borgese et al., 
1993), predicting that both would be myristoylated, as di- 
rectly demonstrated in  a  subsequent  study (Borgese and 
Longhi,  1990).  The  present  work,  which  shows  that  the 
product of one cDNA, coding for cyt b5 reductase, local- 
izes both  to mitochondria  and  to  the  ER,  confirms and 
strengthens  the  conclusion  that  the  same protein  is  tar- 
geted  to  two  biogenetically  independent  membranes. 
However, the  results of this  paper also indicate  that  the 
mechanism of targeting of reductase  to these  two mem- 
branes is different, since localization to the MOM, but not 
to the ER membrane, requires the presence of N-linked 
myristic acid. This was demonstrated by comparing the lo- 
calization of the wt and a nonmyristoylatable G2A mutant 
of reductase in transfected mammalian cells by immuno- 
fluorescence, immuno-EM,  and  cell  fractionation.  Pulse- 
chase experiments suggested that the G2A mutant lost its 
capacity to target to the MOM, while it retained the ability 
to specifically associate with the ER membrane, presum- 
ably via the stretch of 14 uncharged residues close to the 
NH2 terminus. In its ER location, the mutant, like the wt 
reductase, behaved like an integral membrane protein on 
the basis of its resistance to extraction by alkali and its par- 
tition into the detergent phase after treatment with Triton 
X-114. Thus, in agreement with a  previous in vitro study 
(Strittmatter  et  al.,  1993),  our  results  show  that,  also  in 
vivo, N-myristoylation is not required for anchoring of re- 
ductase to the phospholipid bilayer, and, in  addition,  re- 
veal a novel role for the NH2-terminal myristoylated gly- 
cine in protein targeting. 
It is interesting that the yeast homologue of mammalian 
cyt b5 reductase is not myristoylated, but it also contains 
targeting information for the  MOM  at its NH2 terminus 
(Hahne  et  al.,  1994).  The  yeast  reductase  is  partly  an- 
chored  to the  MOM, with the  cytosolic COOH-terminal 
catalytic domain exposed to the  cytosol as  in  mammals, 
Figure  7.  Immunogold-EM localization  of wt and G2A-reductase in stably expressing  MDCK cells. Ultrathin cryosections  obtained 
from wt (A) or G2A (B) reductase--expressing  cells were incubated with anti-PDI antibodies  followed by secondary antibody-10-nm 
gold particle conjugates,  and then with anti-reductase antibodies followed by secondary antibody-5-nm gold particle conjugates, wt re- 
ductase is seen both at the periphery of mitochondria (M, inset) and on PDI-positive structures. The Golgi Complex (G) is negative. (A, 
inset) Mitochondrion at slightly higher magnification, to illustrate  how the labeling is mainly at the periphery of the organelle.  G2A re- 
ductase (B) is seen on PDI-positive structures but is absent from mitochondria (M). (B, inset) Area where labeling of the ER by anti- 
PDI and anti-reductase antibodies  is particularly evident. Arrows in A and B point to some of the 5-nm gold particles,  indicative of the 
presence of reductase.  Bars: (A, inset) 0.1 p,m; (B, inset) 0.125 p~m. 
Borgese et al. Myristic  Acid and Protein Targeting  1509 Table II.  Quantitation of Reductase Immunogold  Labeling in wt and G2A MDCK  Cells 
PDI-positive  areas*  PDl-negative  areas*  Mitochondria 
Total area  Total area  Total area 
examined  5-nm gold  examined  5-nm gold  examined  5-nm gold  Total contour  5-nm gold 
i.vn  2  particles per Ion  2 +- SEM  I.on  2  particles per lain  2 +- SEM  bun  2  particles per ton  e +- SEM  Ixra  particles per bun +- SEM 
wt (6) ¢  18.7  27.4 + 2.9  18.5  10.9 -+ 0.9  4.4  118.0 --+ 11.7  48.1  6.3 --+ 0.8 
G2A (9)  *  15.6  24.4 -+ 3.2  19.7  8.7 -+ 1.4  4.7  12.2 -+ 4.3  40.3  0.6 -+ 0.2 
* PDI-positive  and -negative  areas are the sum of 0.25 × 0.25-1xm  areas containing  more than one gold  particle  or zero  to one gold  particles, respectively  (see  Materials and Meth- 
ods). 
~:Numbets in parentheses refer  to number of negatives  examined. 
cally processed  to become  a  soluble  protein  of the inter- 
membrane  space  (Hahne  et al.,  1994).  No  soluble  reduc- 
tase has been detected in rat mitochondria; rather,  all of it 
is tightly bound to the MOM  (Borgese and Pietrini, 1986) 
and accessible to antibodies and proteases (Meldolesi et al., 
1980).  We cannot  exclude, however, that  a  small fraction 
of MOM-anchored  mammalian reductase  has an inverted 
topology, with the catalytic domain  facing the intermem- 
brane  space  so that  it can  carry  out the  as yet unknown 
function of its yeast counterpart. 
Figure  8.  Analysis  of  cell 
fractions from wt- and G2A- 
MDCK  cells.  (A)  For  each 
cell line,  mitochondrial  (Mr; 
lanes  1  and  5),  heavy  mi- 
crosomal (HMR; lanes 2  and 
6), microsomal (MR; lanes 3 
and 7), and high speed super- 
natant  (sup;  lanes  4  and  8) 
fractions  were  prepared  by 
differential  centrifugation 
from  cells  grown  to  ,~70% 
confluency on  175  cm  2 petri 
dishes  (see  Materials  and 
Methods).  Equal  aliquots  of 
the  cell  fractions,  corre- 
sponding  to  5%  of the  total 
recovered material, were an- 
alyzed  by  11%  SDS-PAGE, 
followed by blotting onto ni- 
trocellulose.  The  blots  were 
cut into three strips: the first, 
from the origin to the 50,000- 
Mr position;  the  second,  en- 
compassing  the  region  be- 
tween 50 and 21,000 kD; and 
the third, from the 21,000-Mr 
position  to  the  front.  The 
three  regions  (from  top  to 
bottom) were probed respec- 
tively  with  anti-ribophorin, 
anti-reductase,  and  anti- 
complex III  antibodies.  The 
latter  recognized  all  the 
polypeptides  of the complex 
(see Materials and Methods), 
but the polypeptide with ap- 
parent  Mr "d3,000  was  cho- 
sen because of its convenient 
position on the gel. Bands were revealed by ECL. (B) Ratio of reductase to ribophorin determined by immunoblotting in cell fractions 
normalized to that ratio found in the MR fraction. Cell fractions from wt- (left) and G2A- (right) MDCK were analyzed as in A, but us- 
ing 125I-protein A  as secondary reagent. The autoradiograms were scanned, and the areas corresponding to the ribophorin and reduc- 
tase bands were determined. The results are averages of three separate experiments  _+ SEM. Filled, striped, and open bars represent 
mitochondrial, heavy microsomal, and microsomal fractions, respectively. (C) Ratio of reductase enzyme activity to ribophorin (deter- 
mined by immunoblotting) in cell fractions. Reductase concentration, determined by the NADH-[Fe(CN)6]  3- reductase activity, was di- 
vided by the ribophorin concentration (peak area per ~1 of cell fraction). The values obtained were normalized to that of the same ratio 
found in the MR fraction. Values refer to one experiment. Bars, as in B. 
The Journal of Cell Biology, Volume 135, 1996  1510 Figure 9.  wt and G2A reductase both behave as integral  mem- 
brane proteins.  A  total membrane fraction obtained from wt- 
(lanes 1, 2, 5, and 6) or G2A- (lanes 3, 4, 7, and 8) MDCK was 
treated with 0.1 M Na2CO3, pH 11.2 (lanes 1-4), or Triton X-114 
(lanes  5-8). After Na2CO3 treatment, the samples were centri- 
fuged to obtain pellet (P) and supernatant (S) fractions.  After 
Triton  X-114 extraction,  the  detergent  (D)  and  aqueous  (A) 
phases were separated. Equal aliquots of P, S, D, and A fractions 
were analyzed by SDS-PAGE followed by ECL immunoblotting 
with  anti-reductase  antibodies.  Numbers on  the  left indicate 
M r  X  10  -3 of molecular weight standards. 
What Is the Role of Myn'stic Acid in Targeting cyt b5 
Reductase to the MOM? 
At present, the structural characteristics of MOM proteins 
required for their targeting have not been identified. The 
targeting sequence(s) is in no case cleaved after insertion 
into the MOM, as occurs for most proteins directed to inter- 
nal mitochondrial subcompartments (for review see Shore 
et al., 1995). While in a few cases a positively charged se- 
quence resembling a matrix-directing signal, followed by a 
hydrophobic  stretch,  seemed  to  constitute  the  targeting 
signal (Hurt et al., 1985;  Hahne et al., 1994), the putative 
matrix-directing signal has not been found on most MOM 
proteins,  and  on  one  protein  on  which  it  is  present 
(mas70p),  it  was  found  to  be  dispensable  for  targeting 
(McBride et al., 1992). The targeting information for the 
MOM often seems to be close to or to coincide with the mem- 
brane-anchoring region; i.e., it is located at the COOH ter- 
minus in proteins anchored by a COOH terminal tail (De 
Silvestris et al., 1995; Mitoma and Ito, 1992; Cao and Dou- 
glas, 1995;  Nguyen et al.,  1993), and at the NH2 terminus 
for proteins with opposite topology (McBride et al., 1992). 
Current  evidence supports  the  idea  that  proteins  des- 
tined for the MOM follow the initial steps of the import 
pathway  taken  by  matrix-directed  protein  precursors 
(Shore et al., 1995; Kiebler et al., 1993).  It is thought that 
MOM proteins, after binding to import receptors on the 
mitochondrial  surface,  somehow  abandon  the  import 
pathway at an early stage, remaining inserted in the outer 
membrane. The picture is complicated by the finding that 
mitochondria have multiple import receptors, which have 
different specificities and may act cooperatively (Haucke 
et al.,  1995).  Thus, different structural features on differ- 
ent proteins could account for targeting to the MOM.  In 
addition,  cytosolic  factors  that  assist  import  of  matrix- 
directed precursors (Hachiya et al., 1993; Murakami et al., 
1992) may also participate in targeting of MOM proteins. 
With this information in mind, what mechanism can be 
proposed fo  r the role of N-linked myristic acid in targeting 
lo  1 
i 0, 
0 
chase time (rain)  0  10  30  220  0  10  30  220 
Rlbophorln  content  0.37  0.35  0.39  0.35  0.37  0.30  0.42  0.36 
(MMHMR) 
Figure 10.  Targeting of wt- and  G2A-reductase analyzed in  a 
pulse-chase  experiment, wt- (left) or G2A- (right) MDCK cells 
were pulse labeled with [35S]methionine +  cysteine  (0.4 mCi/ml 
final concentration) for 5 min, and then incubated in complete 
medium for the indicated  chase times. Mitochondrial  (Mt; filled 
bars) and heavy microsomal (HMR; striped bars) fractions  were 
prepared, and the ribophorin content (peak area by radioimmu- 
noblotting per mg protein) was determined. The ratio of the ribo- 
phorin content in Mt to that in HMR is indicated  on the bottom 
line of the figure. Reductase was immunoprecipitated from the 
fractions, and metabolic specific radioactivity  (ratio of 35S-labeled 
molecules  to total molecules detected by radioimmunoblotting 
with 125I-protein A; see Materials  and Methods) was determined. 
The results shown are averages of values obtained with two sepa- 
rate immunoprecipitates _+ half range. 
of cyt b5 reductase to the MOM?  At present, we do not 
have the means to determine whether wt myristoylated re- 
ductase follows the insertion pathway used by other MOM 
proteins because we have been unable to establish an in 
vitro system reflecting the in vivo targeting specificity. Al- 
though in vitro-synthesized reductase does bind to mem- 
branes in a Na2CO3-resistant fashion (Pietrini et al., 1992), 
we have not  been  able  to demonstrate  specificity in  the 
choice of a  membrane, nor a  temperature or energy re- 
quirement  (unpublished  results).  Factors  operating  in 
vivo, which  limit the nonspecific binding of reductase  to 
phospholipid bilayers, could be absent  from the  in vitro 
system. In addition, efficiency of myristoylation in the cell- 
free system might be low. 
Whether or not  reductase  uses a  general import path- 
way for MOM insertion, we envision two possible roles for 
myristic acid in the targeting: (a) it could be exposed and 
be part of the recognition motif that interacts with compo- 
nents of the MOM or with specific soluble import factors 
and/or chaperones required for MOM targeting; or (b) it 
could have a more indirect role, forcing the NH2-terminal 
portion of reductase into a conformation competent for in- 
teraction with MOM components or soluble targeting fac- 
tors. In other proteins, myristic acid has been observed to 
directly participate in protein-protein interaction, as in the 
case  of  picornavirus  capsid  protein  VP4  (Chow  et  al., 
1987), as well as to influence the overall conformation of 
the acylated protein, as in the case of the Ca2+-free form of 
recoverin (Tanaka et al., 1995). 
Whatever the mechanism by which N-myristoylation af- 
fects  the  targeting of reductase,  the  observations of this 
study provide a demonstration of a strikingly specific role 
of  this  modification  in  membrane  protein  localization. 
Given  the  dramatic  effect that  the  presence  of myristic 
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tase,  it  seems  likely  that  N-myristoylation  has  a  similar 
role in the targeting also of other proteins. 
Targeting to the ER Membrane 
The first step in targeting of integral membrane proteins 
to the ER membrane is generally the cotranslational bind- 
ing of their NH2-terminal signal sequence to signal recog- 
nition particle (SRP) (for review see Walter and Johnson, 
1994). A notable exception to this mechanism is offered by 
the  targeting  of so-called  tail-anchored  proteins,  which 
are integrated in the membrane via a COOH-terminal an- 
chor and expose an NH2-terminal  hydrophilic domain to 
the cytosol (Kutay et al., 1993).  Many tail-anchored pro- 
teins are specifically targeted to the ER membrane by an 
SRP-independent, posttranslational mechanism (Kutay et 
al., 1993; Borgese et al., 1993). In addition, also some NH2- 
terminally "tail-anchored" proteins (NI-I2-terminal  anchor, 
COOH-terminal cytosolic domain), such as NADH-cyt b5 
reductase (Borgese and Gaetani,  1980) and the a  subunit 
of SRP receptor (Andrews et al., 1989), become integrated 
into the ER posttranslationally.  In the context of this dis- 
cussion, we will therefore extend the term "tail-anchored" 
also to NH2-terminally anchored proteins. 
An open question is how specificity in targeting of tail- 
anchored proteins is achieved. In the case of synaptobre- 
vin, there is evidence for the involvement of ER proteins 
(Kutay et al., 1995);  on the other hand, insertion of cyt b5 
(not to be confused with cyt b5 reductase!)  appears to be 
insensitive  to  pretreatment  of the  acceptor  membranes 
with proteases (Verg~res et al., 1995). If ER proteins are 
not involved, one might postulate that particular physico- 
chemical characteristics of the ER bilayer make it compe- 
tent to integrate NH2- and COOHiterminally tail-anchored 
proteins. It also is not clear what kind of sequence or struc- 
tural features tail-anchored proteins must have to be tar- 
geted to the ER. One possibility that we favor is that any 
protein with a hydrophobic stretch close to one of its ex- 
tremities will insert into the ER membrane, unless it car- 
ries a  specific signal for another  organelle, which would 
then compete with the ER for the signal-bearing polypep- 
tide. This hypothesis could account for the double localiza- 
tion, on MOM and ER membranes, of some tail-anchored 
proteins, such as NADH-cyt  b5 reductase (this study and 
references therein) and bcl-2 (Nguyen et al., 1993). A  weak 
MOM targeting signal could allow a portion of these pro- 
teins to escape from the mitochondrial import system and 
to  interact  with the  less specific ER  integration  system. 
This model would also be consistent with the observation 
of this  study  that  the  nonmyristoylated  G2A  reductase 
mutant retains its capacity to associate with the ER, while 
having lost its ability to target to the MOM. While features 
contributed  by  N-myristoylation  would  be  required  for 
recognition by the more specific mitochondrial import ma- 
chinery, the hydrophobic stretch near the NH2 terminus 
would be sufficient for interaction with the more permis- 
sive ER integration system. 
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